Diagenode

News

PRESS RELEASE
April 26, 2013

Researchers Identify Diagenode Kit as Industry-leading Solution for Studying Global DNA Methylation

New benchmarking study published in PLOS ONE shows Diagenode’s MethylCap Kit as best overall methyl binding domain kit for MBD-seq.

Diagenode, Inc., a leading global provider of complete solutions for epigenetics research, was recently cited for having the overall best methyl binding domain (MBD)-based kit in a benchmarking study of five commercially-available MBD-based kits designed to study genome-wide DNA methylation patterns. Aberrant DNA methylation has been associated with various diseases, including most cancers, cardiovascular disease, and Alzheimer's disease, highlighting the significance of the evaluation. Additionally, recent research shows that MBD-based sequencing is the most cost-efficient method for genome wide DNA methylation profiling.

 

Read more

Events

  • Stem Cell Symposium
    Cambridge
    Sep 19-Sep 21, 2018
  • 2018 PacBio User Group Meeting (UGM)
    St Louis
    Sep 19-Sep 20, 2018
  • Livestock Genomics IV
    Wellcome Genome Campus, Hinxton, Cambridge, UK
    Sep 21-Sep 22, 2018
 See all events

Applications

 See all applications



The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.



  ABOUT SSL CERTIFICATES

         Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics